Cell MedX Corp. advised that it now offers access to ongoing observations of actual eBalance Professional (Pro) Series users. The observational reports can be found and will be updated frequently.

New users are being actively solicited to participate in the ongoing research and the Company expects the data will prove extremely useful to its development aims. The eBalance Pro device is designed to study targeted effects on glucose control, increased insulin sensitivity and insulin resistance, abatement of diabetic neuropathy, accelerated wound healing as well as pain management for both non-diabetic and diabetic patients.